美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
71610-276-60	71610-276	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide	Hydrochlorothiazide	TABLET	ORAL	20190513	N/A	ANDA	ANDA040707	Aphena Pharma Solutions - Tennessee, LLC	HYDROCHLOROTHIAZIDE	12.5 mg/1	90 TABLET in 1 BOTTLE (71610-276-60)
53002-1702-0	53002-1702	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide	Hydrochlorothiazide	TABLET	ORAL	20181001	N/A	ANDA	ANDA040707	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	12.5 mg/1	100 TABLET in 1 BOTTLE (53002-1702-0)
53002-1702-3	53002-1702	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide	Hydrochlorothiazide	TABLET	ORAL	20181001	N/A	ANDA	ANDA040707	RPK Pharmaceuticals, Inc.	HYDROCHLOROTHIAZIDE	12.5 mg/1	30 TABLET in 1 BOTTLE (53002-1702-3)
0228-2820-11	0228-2820	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide	Hydrochlorothiazide	TABLET	ORAL	20070312	N/A	ANDA	ANDA040707	Actavis Pharma, Inc.	HYDROCHLOROTHIAZIDE	12.5 mg/1	100 TABLET in 1 BOTTLE (0228-2820-11)
0228-2820-96	0228-2820	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide	Hydrochlorothiazide	TABLET	ORAL	20231201	N/A	ANDA	ANDA040707	Actavis Pharma, Inc.	HYDROCHLOROTHIAZIDE	12.5 mg/1	1000 TABLET in 1 BOTTLE (0228-2820-96)
68071-3443-3	68071-3443	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide	Hydrochlorothiazide	TABLET	ORAL	20230621	N/A	ANDA	ANDA040707	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	12.5 mg/1	30 TABLET in 1 BOTTLE (68071-3443-3)
68071-3491-1	68071-3491	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide	Hydrochlorothiazide	TABLET	ORAL	20230824	N/A	ANDA	ANDA040707	NuCare Pharmaceuticals,Inc.	HYDROCHLOROTHIAZIDE	12.5 mg/1	100 TABLET in 1 BOTTLE (68071-3491-1)
50090-6931-0	50090-6931	HUMAN PRESCRIPTION DRUG	Hydrochlorothiazide	Hydrochlorothiazide	TABLET	ORAL	20231214	N/A	ANDA	ANDA040707	A-S Medication Solutions	HYDROCHLOROTHIAZIDE	12.5 mg/1	90 TABLET in 1 BOTTLE (50090-6931-0)